B

Broncus Holding Corp
HKEX:2216

Watchlist Manager
Broncus Holding Corp
HKEX:2216
Watchlist
Price: 0.49 HKD 6.52% Market Closed
Market Cap: 258.3m HKD
Have any thoughts about
Broncus Holding Corp?
Write Note

Broncus Holding Corp
EPS (Diluted)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Broncus Holding Corp
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
B
Broncus Holding Corp
HKEX:2216
EPS (Diluted)
$0
CAGR 3-Years
13%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
EPS (Diluted)
ÂĄ5
CAGR 3-Years
49%
CAGR 5-Years
77%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
EPS (Diluted)
ÂĄ1
CAGR 3-Years
3%
CAGR 5-Years
16%
CAGR 10-Years
18%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
EPS (Diluted)
ÂĄ10
CAGR 3-Years
16%
CAGR 5-Years
23%
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
EPS (Diluted)
ÂĄ0
CAGR 3-Years
-11%
CAGR 5-Years
9%
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
EPS (Diluted)
ÂĄ2
CAGR 3-Years
30%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Broncus Holding Corp
Glance View

Market Cap
258.3m HKD
Industry
Health Care

Broncus Holding Corp. engages in provision of interventional diagnosis and therapeutics solutions. The company is headquartered in Hangzhou, Zhejiang. The company went IPO on 2021-09-24. The firm's business includes providing diagnostic solutions, lung cancer treatment solutions, chronic obstructive pulmonary disease solutions and navigation platforms. The diagnostic solutions pruducts include FleXNeedle, ATV Sheath, ATV Balloon and others. The lung cancer treatment solutions products include InterVapor for lung cancer, H-Marker and others. The chronic obstructive pulmonary disease (COPD) solutions products include InterVapor for COPD and TLD Ablation System. The navigation platform products include Lungpoint, Lungpro, New Generation Navigation Platform and others.

Intrinsic Value
0.63 HKD
Undervaluation 22%
Intrinsic Value
Price
B

See Also

What is Broncus Holding Corp's EPS (Diluted)?
EPS (Diluted)
-0.1 USD

Based on the financial report for Dec 31, 2023, Broncus Holding Corp's EPS (Diluted) amounts to -0.1 USD.

What is Broncus Holding Corp's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 3Y
13%

Over the last year, the EPS (Diluted) growth was 0%. The average annual EPS (Diluted) growth rates for Broncus Holding Corp have been 13% over the past three years .

Back to Top